• phone 1-855-475-7782 | fax 1-855-475-7787
 

global pharmacy plus review
shop secure
 newsletter

Incruse Ellipta (Umeclidinium) 62.5mcg 30MDI

Product Details

Umeclidinium oral inhalation is used in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema). Umeclidinium inhalation is in a class of medications called anticholinergics. It works by relaxing and opening air passages in the lungs, making it easier to breathe.



Each single inhalation provides a delivered dose (the dose leaving the mouthpiece of the inhaler) of 55 micrograms umeclidinium (equivalent to 65 micrograms of umeclidinium bromide). This corresponds to a pre-dispensed dose of 62.5 micrograms umeclidinium equivalent to 74.2 micrograms umeclidinium bromide.



Our European Brand Name product information:

Incruse Ellipta (Umeclidinium) 55mcg 30MDI

  • Quanity:1 Inhaler
  • Strength: 62.5mcg
Our Brand-Name Price:
$90.00

Availability: In stock

$90.00

There are no products matching the selection.

90.00 In stock